Value through Innovation

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. OUR FOCUS articulates who we are and what we strive for, how we work and what we want to achieve.

Our Global Support Program

Our Global Support Program
Read more on Our Global Support Program
A Unique Bond: human and animal health
A Unique Bond: human and animal health

Vision & Values

A Unique Bond: human and animal health

Celebrating the truly unique bonds between people and their pets.

Read moreon A Unique Bond: human and animal health
Homepage - Our Vision

Our Company

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. 

Read moreon Boehringer Ingelheim
Homepage Banner

Human Pharma

What We Focus On

Human Pharma​ covers the following disease areas; Respiratory, Oncology, Diabetes, and Cardiovascular; and is aimed at providing effective primary and specialist care across indications, in order to improve the quality of life of patients in the Middle East and North Africa. 

Read more on What We Focus On
Animal Health
Animal Health

Animal Health

Dedicated to Protecting and Improving the Health of Animals

We create the future of animal wellbeing. Through our innovative and ground-breaking solutions our highly-skilled employees support all our customers who raise and deeply care for their animals.

Read more on Dedicated to Protecting and Improving the Health of Animals

Careers

Working at Boehringer Ingelheim – Being part of a global family

As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.

Read moreon

Working at Boehringer Ingelheim – Being part of a global family

Explore Our Content

Latest Press Releases

PRESS RELEASE 25 Aug 2020 at 11:55

Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Read more on Boehringer Ingelheim Announces $1.14 Million Support for Lebanon

PRESS RELEASE 25 Aug 2020 at 09:14

Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio-Metabolism, Respiratory Diseases and Stroke Management
Read more on Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio-Metabolism, Respiratory Diseases and Stroke Management

PRESS RELEASE 18 Aug 2020 at 12:59

Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
Read more on Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats